Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/24969
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHobart, J.-
dc.contributor.authorZiemssen, T.-
dc.contributor.authorFEYS, Peter-
dc.contributor.authorLinnebank, M.-
dc.contributor.authorGoodman, A.-
dc.contributor.authorFarrell, R.-
dc.contributor.authorHupperts, R.-
dc.contributor.authorEnglishby, V.-
dc.contributor.authorMcNeill, M.-
dc.contributor.authorChang, I.-
dc.contributor.authorLima, G.-
dc.date.accessioned2017-10-10T08:27:13Z-
dc.date.available2017-10-10T08:27:13Z-
dc.date.issued2017-
dc.identifier.citationEUROPEAN JOURNAL OF NEUROLOGY, 24(SI), p. 434-435 (Art N° EP3162)-
dc.identifier.issn1351-5101-
dc.identifier.urihttp://hdl.handle.net/1942/24969-
dc.description.sponsorshipThis study was funded by Biogen; medical writing support for the development of this abstract was provided by Excel Scientific Solutions and was funded by Biogen.-
dc.language.isoen-
dc.publisherWILEY-
dc.subject.otherClinical Neurology; Neurosciences-
dc.titleProlonged-release fampridine demonstrates rapid and sustained clinically meaningful improvements in walking ability over 24 weeks: MSWS-12 responders in the ENHANCE study-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateJUN, 2017-
local.bibliographicCitation.conferencename3rd Congress of the European-Academy-of-Neurology-
local.bibliographicCitation.conferenceplaceAmsterdam, NETHERLANDS-
dc.identifier.epage435-
dc.identifier.issueSI-
dc.identifier.spage434-
dc.identifier.volume24-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notes[Hobart, J.] Plymouth Univ, Plymouth Hosp NHS Trust, Peninsula Sch Med, Plymouth, Devon, England. [Hobart, J.] Plymouth Univ, Plymouth Hosp NHS Trust, Peninsula Sch Dent, Plymouth, Devon, England. [Ziemssen, T.] Univ Clin Dresden, Dresden, Germany. [Feys, P.] Hasselt Univ, BIOMED REVAL, Diepenbeek, Belgium. [Linnebank, M.] Univ Hosp Witten Herdecke, Witten, Germany. [Goodman, A.] Univ Rochester, Sch Med & Dent, Rochester, NY USA. [Farrell, R.] Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, London, England. [Hupperts, R.] Maastricht Univ, Zuyderland Med Ctr Sittard, Maastricht, Netherlands. [Englishby, V.; McNeill, M.] Biogen, Maidenhead, Berks, England. [Chang, I.; Lima, G.] Biogen, Cambridge, MA USA.-
local.publisher.placeHOBOKEN-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnrEP3162-
dc.identifier.isi000405530100729-
item.contributorHobart, J.-
item.contributorZiemssen, T.-
item.contributorFEYS, Peter-
item.contributorLinnebank, M.-
item.contributorGoodman, A.-
item.contributorFarrell, R.-
item.contributorHupperts, R.-
item.contributorEnglishby, V.-
item.contributorMcNeill, M.-
item.contributorChang, I.-
item.contributorLima, G.-
item.accessRightsOpen Access-
item.fulltextWith Fulltext-
item.fullcitationHobart, J.; Ziemssen, T.; FEYS, Peter; Linnebank, M.; Goodman, A.; Farrell, R.; Hupperts, R.; Englishby, V.; McNeill, M.; Chang, I. & Lima, G. (2017) Prolonged-release fampridine demonstrates rapid and sustained clinically meaningful improvements in walking ability over 24 weeks: MSWS-12 responders in the ENHANCE study. In: EUROPEAN JOURNAL OF NEUROLOGY, 24(SI), p. 434-435 (Art N° EP3162).-
crisitem.journal.issn1351-5101-
crisitem.journal.eissn1468-1331-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
EP3162.pdfPublished version264.13 kBAdobe PDFView/Open
Show simple item record

WEB OF SCIENCETM
Citations

1
checked on May 18, 2024

Page view(s)

18
checked on Sep 7, 2022

Download(s)

4
checked on Sep 7, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.